Truist Financial’s Lunai Bioworks LNAI Stock Holding History

Truist Financial’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-981	Closed	-$572K	–	2820
2021 Q4	$572K	Hold	981	–	–	﹤0.01%	1935
2021 Q3	$528K	Buy	981 +235	+32%	+$115K	﹤0.01%	1968
2021 Q2	$297K	Buy	+746	New	+$243K	﹤0.01%	2374

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Truist Financial's LNAI Position: Q1 2022 in Review

Truist Financial sold out of Lunai Bioworks (LNAI) in Q1 2022, closing a stake of 981 shares — an estimated $572K sold.

Truist Financial first reported a position in LNAI in Q2 2021 and held it in 3 quarters. The position peaked at $572K in Q4 2021. 43 funds tracked by Wall St. Rank hold LNAI as of Q1 2022.

Truist Financial reported no remaining Lunai Bioworks position as of Q1 2022 after selling out during the quarter.
Truist Financial sold 981 Lunai Bioworks shares in Q1 2022, an estimated $572K.
Truist Financial first reported a position in Lunai Bioworks in Q2 2021 and held it in 3 quarters.
Truist Financial's Lunai Bioworks position peaked at $572K in Q4 2021.
43 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.